BindingDB logo
myBDB logout

63 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
8360878 29 Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
8360871 86 Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carEBI Warner-Lambert Company
8515425 65 Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.EBI SmithKline Beecham Pharmaceuticals
1875338 7 Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.EBI Searle R&D and MCR
1875348 65 Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.EBI E. I. du Pont de Nemours& Company, Inc.
1956044 115 Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.EBI Warner Lambert Company
2329554 20 Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.EBI E. I. du Pont de Nemours and Co., Inc.
2329553 81 The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.EBI E. I. du Pont de Nemours& Company, Inc.
2704034 16 Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.EBI Washington State University
16220978 14 Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.EBI Uppsala University
11960488 3 Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.EBI Uppsala University
1469703 14 Dihydropyrimidine angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
 17 1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonistsEBI TBA
 8 Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonistsEBI TBA
 54 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptorEBI TBA
 42 Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureasEBI TBA
 31 Uracil-based angiotensin II receptor antagonistsEBI TBA
 60 The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptorsEBI TBA
 19 2,3,6-Substituted quinazolinones as angiotensin II receptor antagonistsEBI TBA
 56 Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypesEBI TBA
 24 Discovery of nonpeptide potent conformationally restricted angiotensin II receptor antagonistsEBI TBA
 134 Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.EBI TBA
 46 Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinitiesEBI TBA
 10 Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers.EBI TBA
 34 6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonistsEBI TBA
 12 A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonistEBI TBA
 1 Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonistsEBI TBA
 12 Quinoline-4-carboxylic acids as angiotensin II receptor antagonistsEBI TBA
 16 Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activityEBI TBA
 6 Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonistsEBI TBA
 19 Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamideEBI TBA
15115399 41 Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.EBI Università di Siena
12643919 50 Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
12190306 14 Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
8515427 43 Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.EBI Washington University School of Medicine
8510101 37 Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.EBI Warner-Lambert Company
8496939 100 Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.EBI Merck Research Laboratories
8421274 27 Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.EBI Searle & Company
8340920 43 Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists.EBI Searle R&D
8258826 42 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.EBI Dr. Karl Thomae GmbH
8258820 47 A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.EBI DuPont Merck Pharmaceutical Co.
8230127 52 A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.EBI Sanofi Recherche
8201597 10 Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.EBI E. Merck
8057285 44 Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists.EBI Carpibem
2362273 16 Conformational restriction of angiotensin II: cyclic analogues having high potency.EBI G. D. Searle and Company
1920360 13 Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.EBI Ciba Geigy Limited
1635064 8 Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.EBI Lilly Research Laboratories
1433195 55 Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.EBI SmithKline Beecham Pharmaceuticals
1433184 7 Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.EBI Abbott Laboratories